Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 1
2017 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
Biomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act Coverage.
Kesselheim AS, Treasure CL, Joffe S. Kesselheim AS, et al. PLoS Med. 2017 Jan 3;14(1):e1002190. doi: 10.1371/journal.pmed.1002190. eCollection 2017 Jan. PLoS Med. 2017. PMID: 28045970 Free PMC article.
Aaron Kesselheim and colleagues examine orphan-designated drugs approved between 2009 and 2015 in the United States....
Aaron Kesselheim and colleagues examine orphan-designated drugs approved between 2009 and 2015 in the United States....
How Patent Troll Legislation Can Increase Timely Access to Generic Drugs.
Treasure CL, Kesselheim AS. Treasure CL, et al. JAMA Intern Med. 2016 Jun 1;176(6):729-30. doi: 10.1001/jamainternmed.2016.1867. JAMA Intern Med. 2016. PMID: 27183456 No abstract available.
Feedback